MONTE ROSA THERAPEUTICS INC

Ticker: GLUE CUSIP: 61225M102 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 26,187 Value ($000) $411 Avg Close $13.48 Range $7.24 - $19.17
Q3 2025
Shares 24,356 Value ($000) $180 Avg Close $5.30 Range $4.12 - $7.51
Q2 2025
Shares 24,356 Value ($000) $110 Avg Close $4.46 Range $3.50 - $5.47
Q1 2025
Shares 24,356 Value ($000) $113 Avg Close $6.13 Range $4.50 - $7.46
Q4 2024
Shares 24,855 Value ($000) $172 Avg Close $7.50 Range $4.59 - $12.40
Q3 2024
Shares 24,855 Value ($000) $132 Avg Close $5.05 Range $3.52 - $7.05
Q1 2024
Shares 11,419 Value ($000) $81 Avg Close $5.93 Range $4.18 - $8.84
Q4 2023
Shares 18,157 Value ($000) $103 Avg Close $3.92 Range $2.44 - $6.40
Q3 2023
Shares 18,157 Value ($000) $87 Avg Close $6.44 Range $4.47 - $7.90
Q2 2023
Shares 18,157 Value ($000) $124 Avg Close $6.47 Range $4.40 - $8.83
Q1 2023
Shares 18,157 Value ($000) $141 Avg Close $6.95 Range $5.74 - $8.57
Q4 2022
Shares 18,157 Value ($000) $138 Avg Close $8.33 Range $6.51 - $10.96
Q3 2022
Shares 18,157 Value ($000) $148 Avg Close $9.19 Range $6.67 - $12.62
Q2 2022
Shares 18,157 Value ($000) $176 Avg Close $10.05 Range $6.05 - $15.53
Q1 2022
Shares 18,157 Value ($000) $255 Avg Close $13.88 Range $9.82 - $21.56
Q3 2021
Shares 4,756 Value ($000) $106 Avg Close $28.66 Range $18.01 - $45.56